Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a research note published on Saturday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance AMPE opened at $0.25 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.18 and a fifty-two week high […]

Related Keywords

Colorado , United States , Englewood , , Ampio Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Ampio Pharmaceuticals Price Performance , Blackrock Inc , Ampio Pharmaceuticals , Vanguard Group Inc , News Ratings For Ampio Pharmaceuticals Daily , Institutional Investors Weigh In On Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , Free Report , Get Free Report , Street Corp , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Ampe , Medical , 03209t10 , Initiated Coverage , Stocknews Com ,